Balchem (BCPC)
(Real Time Quote from BATS)
$156.41 USD
+1.14 (0.73%)
Updated May 15, 2024 12:40 PM ET
4-Sell of 5 4
F Value A Growth D Momentum D VGM
Brokerage Reports
Balchem Corporation [BCPC]
Reports for Purchase
Showing records 21 - 39 ( 39 total )
Company: Balchem Corporation
Industry: Chemical - Specialty
Top Line In-Line, Bottom Line Beat in 1Q21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Slight Revenue Miss; Earnings In-Line; Raising PT to $145
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Record Revenue Slightly Misses Forecast; 3Q20 Earnings In-Line; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Record Quarter; Bullish Outlook; Raising PT to $126
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
1Q20 Financial Results Modestly Better Than Expected; Lowering PT on Pandemic Impact
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
2019 Financial Results Reported; Modulating PT to $116
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Updating Forecasts; Raising PT to $122 Based on Comparable Universe Re-Rating
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
3Q19 Financials Reported; Minor Top- and Bottom- Line Miss; Raising PT to $110 on Solid Prospects.
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
2Q19 Revenue and Earnings Miss; Reducing Target to $95; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Revenue and Earnings Weakness Offset by Acquisition Transaction; Positive Human Health News; Raising Target to $110
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
FY2018 Financial Results Reported; Record Revenues Reached; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
New Chief Financial Officer Appointed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Energy Sector Headwinds Persist; Reducing Target to $101
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
Company: Balchem Corporation
Industry: Chemical - Specialty
Steady as a Rock; Initiating at Buy and $140 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Balchem Corporation
Industry: Chemical - Specialty
"Top-line Strength Encouraging - Maintain Hold Rating"
Provider: WISCO RESEARCH LLC
Analyst: JANISCH C
Company: Balchem Corporation
Industry: Chemical - Specialty
We are initiating coverage of Balchem with a Hold rating and a one-year price target of $25.
Provider: WISCO RESEARCH LLC
Analyst: JANISCH C
Company: Balchem Corporation
Industry: Chemical - Specialty
EPS slightly below our estimate on higher raw material costs
Provider: SINGULAR RESEARCH
Analyst: GARNER G
Company: Balchem Corporation
Industry: Chemical - Specialty
EPS well above our estimate on stronger than expected revenues. Good operational management and new products drive future growth. Poultry and dairy markets stabilizing. Increasing EPS estimate and reiterate BUY rating
Provider: SINGULAR RESEARCH
Analyst: GARNER G